Evaluation of Compliance to Albumin Use Regulations in Clinical Wards: A Function for Iraqi Clinical Pharmacists in Rational Use of Drugs

Human albumin solution is one of the highly specialized drugs. It is available in governmental (public) hospitals from the company for drugs and medical appliances marketing (KIMADIA) in the approved 20% strength. Due to the wide variety of indications for its use as well as its high cost, it is a strain to keep it available all times in hospitals. This study was a prospective study evaluating the use of albumin in Iraqi governmental hospitals. All patients receiving albumin were documented by clinical pharmacists in the hospitals from Nov 2023 up to Feb 2025. They were 12718 patients. The categorization and analysis was according to the approved Iraqi IV Albumin Administration Guidelines. The results showed that 12.6% of cases were within the highly indicated category, 56.07% were likely indicated, 6.68% were for doubtful indications, and 3.19% were not indicated cases, while the others were not categorized because the indications were not clear for categorization. This study showed that the results were identical to other countries. This means that the problem is the same for using this drug.